definiens: shall mean each unique and distinct disease or con dition in the [COMPANY] Field or [COMPANY] Field, as the case requires . Notwithstan ding the foregoing, a disease or condition will not be considered an for purposes of this Agr eement unless -4- it represents a unique and distinct disease or cond ition, and provided further that the term shall specifically exclude label expansions ( includ ing label expansions for new dosing regimes and/or routes of administration ) or other extension into a different segment of the same disease or condition, including, for example, if Regulatory Approval is s ecured for such disease or condition by submitting a supplemental NDA . For the avoidance of doubt, each cancer type ( e.g., breast cancer, colorectal cancer, lung cancer, prostate cancer, renal cell carcinoma, etc . ) shall be considered a separate Indication fo r purposes of this Agreement . For the further avoidan ce of doubt, this definition of Indication applies only with respect to Milestone Payments